1.150 USD  -0.020 (-1.71%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(AEZS) Community Analysis from
April 23, 2014
(Stock Blog Hub, 1/5/13)
Aeterna Zentaris Inc. (AEZS) recently announced that its oncology candidate, AEZS-108 (doxorubicin peptide conjugate) will be evaluated under US...(read more)
Active traders and day traders have many stocks to choose from this Wednesday morning.  We are tracking news and moves in shares of AEterna Zentaris, Inc. (NASDAQ: AEZS), Finisar, Inc. (NASDAQ: FNSR), JDS Uniphase Corporation (NASDAQ: JDSU), and O...
(Penny Stock DD, 12/5/10)
Many of those who purchased at $1.15 per share following my September 17th article have sent me inquiries about my current view on AEterna Zentaris (AEZS) and where to sell AEZS. AEZS is currently $1.54 per share, which represents nearly a 34% gain in the past 10 weeks. Some may have locked [...]
AEterna Zentaris (AEZS) Company Overview

There is no analysis for AEZS yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here